Patients may have trouble finding two different types of insulin products made by Eli Lilly. The company said it's experiencing a shortage of its 10 mL vials of Humalog and Insulin Lispro ...

Insulin lispro, the rapid-acting component of Humalog Mix75/25, has been shown to be equipotent to Regular human insulin on a molar basis. Instruct patients on diet, exercise, blood or urine ...

(KKTV) - A shortage of Eli Lilly insulin products continues to put Southern Colorado residents in a bind. The company announced last month that their 10-milliliter vials of Humalog and Insulin ...

Eli Lilly’s big-selling insulin, Humalog, faces cut-price competition after the US regulator approved a biosimilar from Sanofi. Sanofi’s Admelog (insulin lispro) is approved in type 1 and type ...

At least in this community, we would all agree that insulin is affordable, especially compared with 10 years ago. Let’s look at the rapid-acting analog. Humalog (Eli Lilly) at GoodRx.com costs $ ...

President and CEO Ned McCoy shared with Becker's some of the company's key objectives for the year, including the launch of some of the first medications from its Petersburg, Va.-based plant, the ...

The patent on Lilly’s most commonly prescribed insulin, Humalog U-100, expired in 2014…and Lilly has filed precisely zero challenges to delay or impede biosimilar competition. We encourage ...

The reason a price cap is being targeted is due to the rapid increase in the cost of insulin products over the last few decades. According to research, one vial of Humalog (insulin lispro ...

Assuming that rapid-acting insulin analogs last for 5 hours is a safe general rule. Examples include Aspart (Novolog) and Lispro (Humalog). Regular human insulin: The onset of regular human ...

The last few years have been tough for the insulin market, with recent policies and high-level pressure forcing companies to ...

The pump and Control-IQ+ are indicated for use with NovoLog or Humalog U-100 insulin. t:slim X2 insulin pump: The pump is intended for the subcutaneous delivery of insulin, at set and variable rates, ...